SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases

NCT06361979 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breasr Cancer

Interventions

DRUG: SHR-A1811
DRUG: Bevacizumab

Sponsor

Huihua Xiong